US Patent

US10842872 — Fluorescein and benoxinate compositions

Method of Use · Assigned to Paragon Bioteck Inc · Expires 2037-11-15 · 11y remaining

Vulnerability score 62/100 Moderate — design-around opportunities exist

What this patent protects

This patent describes compositions of fluorescein and benoxinate, specifically benoxinate hydrochloride, and their corresponding uses.

USPTO Abstract

Compositions comprising a fluorescein component and benoxinate component and the corresponding uses of these compositions are described herein. These compositions have improved storage life and the fluorescein component and/or benoxinate component minimally degrade after 12 to 18 months of storage.

Drugs covered by this patent

benoxinate-hydrochloride (BENOXINATE HYDROCHLORIDE)

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3001`	—	benoxinate-hydrochloride

Patent Metadata

Patent number: US10842872
Jurisdiction: US
Classification: Method of Use
Expires: 2037-11-15
Drug substance claim: No
Drug product claim: No
Assignee: Paragon Bioteck Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.